1. Home
  2. ITRM vs OMEX Comparison

ITRM vs OMEX Comparison

Compare ITRM & OMEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRM
  • OMEX
  • Stock Information
  • Founded
  • ITRM 2015
  • OMEX 1986
  • Country
  • ITRM Ireland
  • OMEX United States
  • Employees
  • ITRM N/A
  • OMEX N/A
  • Industry
  • ITRM Biotechnology: Pharmaceutical Preparations
  • OMEX Marine Transportation
  • Sector
  • ITRM Health Care
  • OMEX Consumer Discretionary
  • Exchange
  • ITRM Nasdaq
  • OMEX Nasdaq
  • Market Cap
  • ITRM 40.0M
  • OMEX 44.8M
  • IPO Year
  • ITRM 2018
  • OMEX N/A
  • Fundamental
  • Price
  • ITRM $0.76
  • OMEX $1.27
  • Analyst Decision
  • ITRM Strong Buy
  • OMEX
  • Analyst Count
  • ITRM 2
  • OMEX 0
  • Target Price
  • ITRM $7.00
  • OMEX N/A
  • AVG Volume (30 Days)
  • ITRM 1.0M
  • OMEX 2.2M
  • Earning Date
  • ITRM 08-05-2025
  • OMEX 09-02-2025
  • Dividend Yield
  • ITRM N/A
  • OMEX N/A
  • EPS Growth
  • ITRM N/A
  • OMEX N/A
  • EPS
  • ITRM N/A
  • OMEX N/A
  • Revenue
  • ITRM N/A
  • OMEX $620,048.00
  • Revenue This Year
  • ITRM N/A
  • OMEX N/A
  • Revenue Next Year
  • ITRM $270.19
  • OMEX N/A
  • P/E Ratio
  • ITRM N/A
  • OMEX $49.25
  • Revenue Growth
  • ITRM N/A
  • OMEX N/A
  • 52 Week Low
  • ITRM $0.66
  • OMEX $0.27
  • 52 Week High
  • ITRM $3.02
  • OMEX $5.25
  • Technical
  • Relative Strength Index (RSI)
  • ITRM 41.71
  • OMEX 41.17
  • Support Level
  • ITRM $0.80
  • OMEX $1.43
  • Resistance Level
  • ITRM $0.91
  • OMEX $1.71
  • Average True Range (ATR)
  • ITRM 0.06
  • OMEX 0.14
  • MACD
  • ITRM 0.02
  • OMEX -0.04
  • Stochastic Oscillator
  • ITRM 41.08
  • OMEX 3.70

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About OMEX Odyssey Marine Exploration Inc.

Odyssey Marine Exploration Inc is a deep-ocean exploration company. The company provides specialized mineral exploration, project development, and marine services to clients. It is engaged in the discovery, validation, and development of subsea mineral deposits in a socially and environmentally responsible manner. The company works with governments to identify mineral resources in Exclusive Economic Zones, focusing on phosphorite (fertilizer) and polymetallic nodules (battery metals) projects. Its projects include the ExO Phosphate project, CIC, Ocean Minerals, and the LIHIR Gold project.

Share on Social Networks: